COPIKTRA: TREATMENT OF MIGRAINE IN ADULTS

Copiktra is used in treatment of Chronic Lymphocytic Leukemia and Follicular Lymphoma. It contain active ingredient was Duvelisib. Strength of copiktra was 15 mg and 25 mg. it is approved by an FDA 24/09/2018.It is available capsule. For more details click here.